Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina

Clinical Microbiology and Infection

Volumn 14, Issue 8, 2008, Pages 805-807

  Wallach, J C ^a   Ferrero, M C ^b   Victoria Delpino, M ^b   Fossati, C A ^b   Baldi, P C ^b  

^a HOSPITAL F J MUÑIZ   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Biosafety; Brucella abortus S19 vaccine; Human brucellosis; Laboratory workers occupational exposure

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BRUCELLA VACCINE; DOXYCYCLINE; GENTAMICIN; RIFAMPICIN;

ADULT; ARGENTINA; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BLOOD CULTURE; BRUCELLA ABORTUS; BRUCELLOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DRUG INDUSTRY; HUMAN; INDUSTRIAL WORKER; INFECTION RISK; MICROBIOLOGICAL EXAMINATION; NONHUMAN; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; VACCINE PRODUCTION;

BRUCELLA MELITENSIS BIOVAR ABORTUS;

EID: 48449094304     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02029.x     Document Type: Editorial

References (16)

1. Moriyón I, Grilló MJ, Monreal D et al. Rough vaccines in animal brucellosis: Structural and genetic basis and present status. Vet Res 2004; 35: 1-38.
2. Blasco JM. A review of the use of B. melitensis Rev. 1 vaccine in adult sheep and goats. Prev Vet Med 1997; 31: 275-283.
3. Bekerlman RL. Human illness associated with use of veterinary vaccines. Clin Infect Dis 2003; 37: 407-414.
4. Ashford DA, di Pietra J, Lingappa J et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine 2004; 22: 3435-3439.
5. Blasco JM, Diaz R. Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet 1993; 342: 805.
6. Vincent P, Joubert L, Prave M. Two occupational cases of brucellar infection after inoculation of B.19 vaccine. Bull Acad Vet Fr 1970; 43: 89-97.
7. Olle-Goig JE, Canela-Soler J. An outbreak of Brucella melitensis infection by airborne transmission among laboratory workers. Am J Public Health 1987; 77: 335-338.
8. Alton GG, Jones LM, Angus RD et al. Techniques for the brucellosis laboratory, 2nd edn. Paris, France: Institut National de la Recherché Agronomique, 1988.
9. Young EJ. Clinical manifestations of human brucellosis. In: Young EJ, Corbel MJ, eds. Brucellosis: Clinical and laboratory aspects. Boca Raton, FL: CRC Press, 1989; 114-116.
10. Hall WH. Modern chemotherapy for brucellosis in humans. Rev Infect Dis 1990; 12: 1060-1099.
11. Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerg Infect Dis 2005; 11: 1180-1185.
12. Staszkiewicz J, Lewis CM, Colville J et al. Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. J Clin Microbiol 1991; 29: 287-290.
13. Memish ZA, Mah MW. Brucellosis in laboratory workers at a Saudi Arabian hospital. Am J Infect Control 2001; 29: 48-52.
14. Martin-Mazuelos E, Nogales MC, Florez C et al. Outbreak of Brucella melitensis among microbiology laboratory workers. J Clin Microbiol 1994; 32: 2035-2036.
15. Young EJ. Brucella antibodies in veterinarians exposed to Strain 19. In: Garry Adams L, ed. Advances in brucellosis research. College Station, TX: Texas A&M University Press, 1990; 465.
16. Yagupsky P, Peled N, Riesenberg K et al. Exposure of hospital personnel to Brucella melitensis and occurrence of laboratory-acquired disease in an endemic area. Scand J Infect Dis 2000; 32: 31-35.